Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

Full Year 2017 Financial Results

Genmab will report its full  year 2017 financial results after market close on February 21. An investor conference call to discuss the results will be held at 6:00 PM CET / 12:00 PM EST on February 21. To join the call by phone, dial one of the following numbers and ask fro the Genmab conference call: +45 35 15 81 21 in Denmark, +44 (0)330 336 9411 in the UK or +1 646-828-8156 in the US. Click here to listen to the webcast.

news email 150x110InvestorPortal

To register your email address for electronic shareholder communications or to update your settings, log on to the InvestorPortal


Career Opportunities at Genmab

Genmab is seeking new employees to join our team. Visit our Careers webpages to explore current vacancies, learn about our culture and meet some of our team members